A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis

Edith A. Perez

Research output: Contribution to journalReview article

17 Scopus citations

Fingerprint Dive into the research topics of 'A risk-benefit assessment of serotonin 5-HT<sub>3</sub> receptor antagonists in antineoplastic therapy-induced emesis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds